Farnesyltransferase inhibitors

Details for Australian Patent Application No. 2001297704 (hide)

Owner Abbott Laboratories

Inventors Rockway, Todd, W.; Wang, Xilu; Claiborne, Akiyo, K.; Sham, Hing, L.; Li, Tomgmei; Gwaltney, Stephen, L, II; Mantei, Robert, A.; Wand, Le; Lin, NanHorng; Wang, Gary, T.; Tong, Yunsong; Wang, Weibo; Hasvold, Lisa, A.; Sullivan, Gerard, M.; Li, Qun

Agent Spruson & Ferguson

Pub. Number AU-B-2001297704

PCT Number PCT/US01/43168

PCT Pub. Number WO2002/074747

Priority 09/727,230 30.11.00 US; 09/912,677 25.07.01 US

Filing date 30 November 2001

Wipo publication date 3 October 2002

Acceptance publication date 27 September 2007

International Classifications

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/30 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/727,230 30.11.00 US; 09/912,677 25.07.01 US

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2001297704

27 September 2007 Application Accepted

  Published as AU-B-2001297704

24 January 2008 Standard Patent Sealed

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001297705-REAL TIME INTERNET TRANSCRIPT PRESENTATION SYSTEM

2001297703-CD19-specific redirected immune cells